Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate
Awards & highlights
Study Summary
This trial tests a rapid diagnostic panel to detect COVID-19, Influenza A, and Influenza B in nasal swabs. Will help with CE conformity assessment.
Eligible Conditions
- COVID-19
- Flu
- Flu Type B
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Secondary outcome measures
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nasal sampling/Testing (Professional Use)Experimental Treatment1 Intervention
operators will collect one mid-turbinate nasal swab sample from both nostrils from each subject. The collected mid-turbinate nasal swab will be tested with the Panbio™ Rapid Panel by an operator at the study site in a Near Patient Testing setting (e.g. GP centre or hospital clinic). After the mid-turbinate nasal sampling, the operators will collect one NP swab sample from one nostril of each subject.UTM samples will be shipped to the Core Laboratory for testing with RT-PCR protocols for Flu A, Flu B and SARS-CoV-2, as per the laboratory manual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Panbio™
2023
N/A
~2040
Find a Location
Who is running the clinical trial?
Abbott Rapid DxLead Sponsor
5 Previous Clinical Trials
6,602 Total Patients Enrolled
4 Trials studying COVID-19
5,579 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently experiencing frequent nosebleeds or have recently suffered a facial injury.You have taken any antiviral medications for the flu or COVID-19 in the last 30 days.
Research Study Groups:
This trial has the following groups:- Group 1: Nasal sampling/Testing (Professional Use)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are enrolled in this research endeavor?
"Indeed, records present on clinicaltrials.gov confirms that this medical experiment is currently recruiting participants. This study was posted online in mid-December and has been updated since then; 1531 people need to be registered from a single site."
Answered by AI
Is there an open call for volunteers for this research project?
"Affirmative. Information available on clinicaltrials.gov states that this investigation has been actively recruiting since December 15th 2022 and was last updated on the 21st of the same month. In total, 1 site is looking for 1531 participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger